Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Traws Pharma, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +4 vs. Q3 2025
- Shares held
- 3.42M
- +2.11M (+162.0%) vs. Q3 2025
- Total value
- $3.86M
- +$1.45M (+60.1%) vs. Q3 2025
- New holders
- 9
- 6 more added
- Sold out
- 5
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $1 | 0.00% | −3,527−100.0% | Reduced |
| FMR LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Robinswood Financial LLC | 5 | $5 | 0.00% | +5 | New |
| Advisor Group Holdings, Inc. | 8 | $9 | 0.00% | +8 | New |
| Bank of America Corp | 113 | $128 | 0.00% | +11+10.8% | Added |
| SBI Securities Co., Ltd. | 162 | $183 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,722 | $8.73K | 0.00% | +7,716+128,600.0% | Added |
| BlackRock, Inc. | 9,956 | $11.3K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,197 | $16.0K | 0.00% | +14,197 | New |
| Two Sigma Investments, LP | 19,244 | $21.7K | 0.00% | −2,774−12.6% | Reduced |
| Citadel Advisors LLC | 24,819 | $28.0K | 0.00% | +24,819 | New |
| State Street Corp | 25,802 | $29.2K | 0.00% | +25,802 | New |
| XTX Topco Ltd | 42,210 | $47.7K | 0.00% | +31,502+294.2% | Added |
| Seven Fleet Capital Management LP | 49,260 | $55.7K | 0.04% | +49,260 | New |
| Geode Capital Management, LLC | 61,653 | $69.7K | 0.00% | +18,213+41.9% | Added |
| Vanguard Group Inc | 87,259 | $98.6K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 154,431 | $174.5K | 0.01% | +154,431 | New |
| Boothbay Fund Management, LLC | 194,536 | $219.8K | 0.01% | +194,536 | New |
| OrbiMed Advisors LLC | 605,531 | $684.3K | 0.01% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 678,142 | $766.3K | 0.10% | +649,649+2,280.0% | Added |
| Squadron Capital Management LLC | 713,540 | $806.3K | 0.36% | +713,540 | New |
| Adage Capital Partners GP, L.L.C. | 730,000 | $824.9K | 0.00% | +400,000+121.2% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,573−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −719−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |